sent moments ago...

Dear Dr. Shokat

RE: COVID19 potential treatment JQ1 is inferior to, and less safe, than Apabetalone (RVX-208)

Please consider testing Apabetalone (RVX-208) against COVID19, especially so in elderly with DM, CVD and CKD.
Apabetalone just received FDA Breakthrough Therapy Designation for Diabetic CVD.  Super safe drug.  Selective BET inhibition is key.    Thank you for your consideration.

Contact Resverlogix corp for more information. 
Email: ir@resverlogix.com
Phone: 403-254-9252
Or visit our website: www.resverlogix.com

https://cardiology2.com/resverlogix-receives-us-fda-breakthrough-therapy-designation-for-apabetalone/